Overview
Clinical phenotype terms— hover any for plain English:
FDA & Trial Timeline
10 eventsDana-Farber Cancer Institute — PHASE2
University of California, San Diego — PHASE1
Ningbo Newbay Technology Development Co., Ltd — PHASE2, PHASE3
Kumquat Biosciences Inc. — PHASE2
Second Affiliated Hospital, School of Medicine, Zhejiang University — PHASE2
The First Affiliated Hospital with Nanjing Medical University — NA
Universität Duisburg-Essen
GlaxoSmithKline — PHASE3
Asan Medical Center — PHASE1, PHASE2
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
4 availableImatinib Mesylate
Patients with Kit (CD117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumors (GIST)
Stivarga
indicated for the treatment of adult patients with locally advanced, unresectable or metastatic gastrointestinal stromal tumor (GIST) who have been previously treated with imatinib mesylate and suniti…
indicated for the treatment of adult patients with locally advanced, unresectable or metastatic gastrointestinal stromal tumor (GIST) who have been previously treated with imatinib mesylate and sunitinib malate
Ayvakit
Treatment of adults with unresectable or metastatic GIST harboring a platelet-derived growth factor receptor alpha (PDGFRA) exon 18 mutation, including PDGFRA D842V mutations
Imatinib Mesylate
Treatment of patients with Kit (CD117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumors (GIST)
Rare Disease Specialist
Rare Disease Specialist
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Financial Resources
2 resourcesTravel Grants
No travel grants are currently matched to Gastrointestinal stromal tumor.
Community
No community posts yet. Be the first to share your experience with Gastrointestinal stromal tumor.
Start the conversation →Latest news about Gastrointestinal stromal tumor
Disease timeline:
New recruiting trial: The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study
A new clinical trial is recruiting patients for Gastrointestinal stromal tumor
New recruiting trial: Graded Insulin Suppression Test P&F
A new clinical trial is recruiting patients for Gastrointestinal stromal tumor
New recruiting trial: iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
A new clinical trial is recruiting patients for Gastrointestinal stromal tumor
New recruiting trial: Apatinib Mesylate Versus Standard Second-line TKI in the Treatment of Advanced GIST
A new clinical trial is recruiting patients for Gastrointestinal stromal tumor
New recruiting trial: Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
A new clinical trial is recruiting patients for Gastrointestinal stromal tumor
New recruiting trial: Safety of Robotic Surgery for GISTs at Special Anatomic Sites
A new clinical trial is recruiting patients for Gastrointestinal stromal tumor
New recruiting trial: 5 Years of Adjuvant Imatinib in Patients With Gastrointestinal Stromal Tumor With a High Risk
A new clinical trial is recruiting patients for Gastrointestinal stromal tumor
New recruiting trial: Clinical Research of Drug Holiday Based on MRD Detection in GIST Patients at High Risk of Recurrence
A new clinical trial is recruiting patients for Gastrointestinal stromal tumor
New recruiting trial: Prediction of Postoperative Treatment Efficacy and Recurrence Risk of High-risk GIST Based on Liquid Biopsy MRD
A new clinical trial is recruiting patients for Gastrointestinal stromal tumor
New recruiting trial: Observational Registry Data on GIST Patients
A new clinical trial is recruiting patients for Gastrointestinal stromal tumor
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Gastrointestinal stromal tumor
Are there clinical trials for Gastrointestinal stromal tumor?
Yes — 20 recruiting clinical trials are currently listed for Gastrointestinal stromal tumor on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Gastrointestinal stromal tumor?
25 specialists and care centers treating Gastrointestinal stromal tumor are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.
What treatment and support options exist for Gastrointestinal stromal tumor?
1 patient support program are currently tracked on UniteRare for Gastrointestinal stromal tumor. See the treatments and support programs sections for copay assistance, eligibility, and contact details.